About Cell Signal
Cell Signal is a Healthcare company based in United States founded in 1999. Reagents and services for Cell Biology and Proteomics research. Its website cellsignal.com draws about 488 thousand monthly visits. Cell Signal offers products and services including Primary Antibodies, ELISA Kits, Proteomic Analysis Products, and SignalStar Multiplex IHC Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is CELL SIGNALING TECHNOLOGY, INC. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1999, Cell Signaling Technologies operates as a private biotech company in the United States, focused on the development, manufacture, and marketing of reagents and assays for cell biology and proteomics. Products include primary and secondary antibodies, ELISA kits, ChIP reagents, pathway modulators, and the CellSimple benchtop analysis system for cellular assays. Proteomics services encompass PTMScan methods for post-translational modification profiling via antibody enrichment and LC-MSMS.
- Latest Funding Round$710.84K (USD), Grant
Sep 2009
- Investors
Products & Services of Cell Signal
Cell Signal offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, Proteomic Analysis Products, and SignalStar Multiplex IHC Kits.
Antibodies for detecting proteins in biological samples.
Kits for measuring proteins via enzyme-linked assays.
Products for protein analysis in research settings.
Kits for multiplex immunohistochemistry applications.
Apps and channels of Cell Signal
its YouTube channel Cell Signaling Technology, Inc. has 27.1K subscribers and 30 videos.
Videos from Cell Signal
The most watched videos on Cell Signal's YouTube channel, Cell Signaling Technology, Inc. (27.1K subscribers). Click a video to play it here.
More on Cell Signaling Technology, Inc..
Funding Insights of Cell Signal
- Total Rounds 3
- Last Round Grant — $710,835
- First Round $710,835
(Jul 2007)
- Investors Count 1
All 3 funding rounds of Cell Signal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Cell Signal
Cell Signal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Cell Signal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cell Signal
136 people are tracked at Cell Signal (43 in leadership, 93 in team).
| Name | Role | Group |
|---|---|---|
Margaret Murray | Executive Director, Global Human Resources | Leadership |
Andrea Russello | Executive Director, Global Production & Technical Support | Leadership |
Seneca Stone | Vice President, Global Supply Chain | Leadership |
Ginna Kitoski | Sr. HR Business Partner Leader, Global Operations | Leadership |
Sanja Souza | Senior Human Resources Business Partner | Leadership |
Michelle F. | Sr. HR Business Partner / HRBP Team Leader | Leadership |
Sean Beausoleil | Executive Director, Research | Leadership |
Reggie Prioli | Associate Director Conjugation | Leadership |
Herbert Haack | Director, Translational Diagnostics | Leadership |
James Lorenzen | Director, Antibody Development Core | Leadership |
Reaiah Brown Johnson | Head Of Global Talent Management And Diversity Equity & Inclusion | Leadership |
Maggie Xie | VP & General Manager, Greater China | Leadership |
Kazuyuki Kiyota | VP & General Manager, Japan | Leadership |
Matthew Curran | CFO | Leadership |
Craig M. Thompson | Chief Operating Officer | Leadership |
Roberto Polakiewicz | Chief Scientific Officer | Leadership |
Michael J. Comb | President & CEO | Leadership |
Christopher Salvadore | Associate Director, Strategic Alliances | Leadership |
Brian McDonough | Associate Director | Leadership |
Andrew Romano | Director Of Business Development | Leadership |
116 more people are available in the full profile.
Complete people profiles for Cell Signal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cell Signal
3 dated milestones of Cell Signal across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Cell Signal is founded.
- Funding First funding round of $711K.
- Funding Latest funding round, Grant, of $711K.
Competitors of Cell Signal
Cell Signal has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Cell Signal
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cell Signal
The website of Cell Signal (cellsignal.com) receives about 488.2K visits a month and ranks #114,694 among all websites worldwide, #7,333 in Biology.
- Monthly visits488.2K
▲ 9.4% vs previous month
- Unique visitors184.9K
per month
- Global rank#114,694
among all websites
- Category rank#7,333
Science and Education · Biology
- Bounce rate46%
- Pages per visit2.4
- Average visit2 min 00 sec
- DevicesDesktop 67% · Mobile 33%
Websites whose visitors overlap most with Cell Signal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
| scbt.com | 87% | 444.3K | #138,937 | View details | |
| rndsystems.com | 84% | 349K | #159,292 | View details | |
| novusbio.com | 69% | 199.6K | #232,152 | View details | |
| ptglab.com | 66% | #137,673 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Cell Signal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cell Signal (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cell Signal
Complete news archive for Cell Signal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cell Signal
Cell Signal was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Cell Signal is headquartered in United States.
Founded in 1999, Cell Signaling Technologies operates as a private biotech company in the United States, focused on the development, manufacture, and marketing of reagents and assays for cell biology and proteomics. Products include primary and secondary antibodies, ELISA kits, ChIP reagents, pathway modulators, and the CellSimple benchtop analysis system for cellular assays. Proteomics services encompass PTMScan methods for post-translational modification profiling via antibody enrichment and LC-MSMS.
Cell Signal's top competitors include GenScript, Epitomics and Vector Laboratories.
Cell Signal offers Primary Antibodies, ELISA Kits, Proteomic Analysis Products, and SignalStar Multiplex IHC Kits.
Cell Signal has 1 investor. Key investors include HHS.
Cell Signal operates through Cell Signaling Technology, Inc..
The website of Cell Signal receives about 488 thousand visits a month and ranks #114,694 among all websites worldwide.